Advancing Biopharmaceuticals
and Medical Technologies
in Cardiovascular Medicine

COVID-19 Keeping up trial safety and progress

Services

Accelerate Your Research in Cardiovascular Trials

is a full-service contract research organization (CRO) specialized in cardiovascular research. Our services cover the whole spectrum of development.

References

We Share Your Enthusiasm for Finding Effective Therapies

works with biopharmaceutical and medical technology companies across all phases of development. Our deep expertise in cardiovascular medicine makes us a strong partner for your cardiovascular trials.

About

Together We Find the Right Solution

Accessible and responsive leadership, dedicated staff, and a specialized site network – this is how we help study sponsors develop innovative therapies.

References

Clients & Partners

BLOG

Discover the latest updates on cardiovascular research

Logo of the THT Conference 2025 in Boston, featuring the event's name and stylized heart graphic. Below the logo, text displays the conference dates, February 11-13, 2025, and location details. The background is clean and professional with a medical and scientific theme, emphasizing the focus on cardiovascular research and therapy advancements
Fairs

SCIRENT at THT 2025 in Boston: Commitment and Expertise in Cardiovascular Research

As a leading Contract Research Organization specializing in cardiovascular research, SCIRENT is eager to join the THT Conference in Boston from February 11-13, 2025. This conference is a crucial hub for professionals to exchange information about advanced therapies and technologies. We take pride...
A senior female researcher, focused and diligent, writes notes while analyzing data in a modern laboratory environment. She is part of a team dedicated to developing innovative treatments aimed at improving patient outcomes worldwide. The image highlights her concentration and expertise in the field of clinical research.
Insights

Milestones Achieved: PEI Approval and First Participant Dosed in TGD001 Phase 1 Study

At SCIRENT, we are excited to work for TargED Biopharmaceuticals B.V. in developing TGD001, an innovative thrombolytic therapy for thrombotic diseases.  PEI Approval in Record Time In October 2024, TargED Biopharmaceuticals B.V. received approval from the Paul-Ehrlich-Institut (PEI) for a...
Logo for the ESC Congress 2024 in London, featuring colorful circuit-like paths forming a heart shape
Fairs

SCIRENT at ESC Congress 2024: Pioneering Cardiovascular Research

Date: Friday, August 30 - Monday, September 2, 2024 Location: London, United Kingdom We are thrilled to announce that SCIRENT, a leading European cardiovascular clinical research organization, will be participating in this year's ESC Congress 2024 in London. Visit us...

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Thank you for your application.

We will get in touch shortly.